Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Cancer

Explore clinical trials studying Fallopian Tube Cancer. Study availability and eligibility vary by location and protocol.

335 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Cancer trial results

Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adnexal Diseases, +55 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic (Arizona) Scottsdale, Arizona, United States
  • University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 82 locations
View Trial Details
Recruiting

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

NCT05460000

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
Locations
  • Universitätsklinik Innsbruck Innsbruck, Austria
  • Cliniques Universitaires St. Luc Brussels, Belgium
  • UZ Gent Ghent, Belgium
  • Jessa ziekenhuis Hasselt, Belgium
View all 50 locations
View Trial Details
Recruiting

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

NCT06906341

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +25 more
Locations
  • 004 Birmingham, Alabama, United States
  • 150 Palo Alto, California, United States
  • 014 San Francisco, California, United States
  • 544 Fort Myers, Florida, United States
View all 49 locations
View Trial Details
Recruiting

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

NCT05887609

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • City of Hope Lennar Irvine, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • University of Pennsylvania Health System, Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

NCT05429970

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +32 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

NCT05377996

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +34 more
Locations
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • UCLA David Geffen School of Medicine, Division of Hematology/Oncology Santa Monica, California, United States
View all 26 locations
View Trial Details
Recruiting

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

NCT05287451

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • WU St Louis St Louis, Missouri, United States
  • Mount Sinai Health System New York, United States
View Trial Details

Related conditions